A positive family history is a strongly associated risk factor for melanoma [58]–[62], and approximately 50% of affected families have mutations in one of the three following genes: cyclin-dependent kinase inhibitor 2A (CDKN2A), alternate reading frame (ARF), and cyclin-dependent kinase 4 (CDK4). Here, CDK4 is linked to melanoma.